{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T21:53:24Z","timestamp":1776290004997,"version":"3.50.1"},"publisher-location":"Cham","reference-count":262,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030916213","type":"print"},{"value":"9783030916237","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-3-030-91623-7_11","type":"book-chapter","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T19:02:39Z","timestamp":1647284559000},"page":"107-134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Phosphate Is a Cardiovascular Toxin"],"prefix":"10.1007","author":[{"given":"Maren","family":"Leifheit-Nestler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Richter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"issue":"15","key":"11_CR1","doi-asserted-by":"publisher","first-page":"7071","DOI":"10.1073\/pnas.91.15.7071","volume":"91","author":"MP Kavanaugh","year":"1994","unstructured":"Kavanaugh MP, Miller DG, Zhang W et al (1994) Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci U S A 91(15):7071\u20137075. https:\/\/doi.org\/10.1073\/pnas.91.15.7071","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"41","key":"11_CR2","doi-asserted-by":"publisher","first-page":"25426","DOI":"10.1016\/S0021-9258(18)47267-5","volume":"269","author":"Z Olah","year":"1994","unstructured":"Olah Z, Lehel C, Anderson WB et al (1994) The cellular receptor for gibbon ape leukemia virus is a novel high affinity sodium-dependent phosphate transporter. J Biol Chem 269(41):25426\u201325431. https:\/\/doi.org\/10.1016\/S0021-9258(18)47267-5","journal-title":"J Biol Chem"},{"issue":"4","key":"11_CR3","doi-asserted-by":"publisher","first-page":"F691","DOI":"10.1152\/ajprenal.90623.2008","volume":"296","author":"R Villa-Bellosta","year":"2009","unstructured":"Villa-Bellosta R, Ravera S, Sorribas V et al (2009) The Na+-Pi cotransporter PiT-2 (SLC20A2) is expressed in the apical membrane of rat renal proximal tubules and regulated by dietary Pi. Am J Physiol Ren Physiol 296(4):F691\u2013F699. https:\/\/doi.org\/10.1152\/ajprenal.90623.2008","journal-title":"Am J Physiol Ren Physiol"},{"issue":"6","key":"11_CR4","doi-asserted-by":"publisher","first-page":"F1341","DOI":"10.1152\/ajprenal.00375.2009","volume":"298","author":"Y Tomoe","year":"2010","unstructured":"Tomoe Y, Segawa H, Shiozawa K et al (2010) Phosphaturic action of fibroblast growth factor 23 in Npt2 null mice. Am J Physiol Ren Physiol 298(6):F1341\u2013F1350. https:\/\/doi.org\/10.1152\/ajprenal.00375.2009","journal-title":"Am J Physiol Ren Physiol"},{"issue":"3","key":"11_CR5","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00424-010-0841-1","volume":"460","author":"N Picard","year":"2010","unstructured":"Picard N, Capuano P, Stange G et al (2010) Acute parathyroid hormone differentially regulates renal brush border membrane phosphate cotransporters. Pflugers Arch 460(3):677\u2013687. https:\/\/doi.org\/10.1007\/s00424-010-0841-1","journal-title":"Pflugers Arch"},{"issue":"3","key":"11_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10741-017-9615-6","volume":"22","author":"EC Christopoulou","year":"2017","unstructured":"Christopoulou EC, Filippatos TD, Megapanou E et al (2017) Phosphate imbalance in patients with heart failure. Heart Fail Rev 22(3):349\u2013356. https:\/\/doi.org\/10.1007\/s10741-017-9615-6","journal-title":"Heart Fail Rev"},{"issue":"7120","key":"11_CR7","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa I, Yamazaki Y, Shimada T et al (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444(7120):770\u2013774. https:\/\/doi.org\/10.1038\/nature05315","journal-title":"Nature"},{"issue":"3","key":"11_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y et al (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19(3):429\u2013435. https:\/\/doi.org\/10.1359\/JBMR.0301264","journal-title":"J Bone Miner Res"},{"issue":"3","key":"11_CR9","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1113\/expphysiol.2005.032516","volume":"91","author":"J Marks","year":"2006","unstructured":"Marks J, Srai SK, Biber J et al (2006) Intestinal phosphate absorption and the effect of vitamin D: a comparison of rats with mice. Exp Physiol 91(3):531\u2013537. https:\/\/doi.org\/10.1113\/expphysiol.2005.032516","journal-title":"Exp Physiol"},{"issue":"3","key":"11_CR10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1172\/JCI106532","volume":"50","author":"ZS Agus","year":"1971","unstructured":"Agus ZS, Puschett JB, Senesky D et al (1971) Mode of action of parathyroid hormone and cyclic adenosine 3\u2032,5\u2032-monophosphate on renal tubular phosphate reabsorption in the dog. J Clin Invest 50(3):617\u2013626. https:\/\/doi.org\/10.1172\/JCI106532","journal-title":"J Clin Invest"},{"issue":"5","key":"11_CR11","doi-asserted-by":"publisher","first-page":"F792","DOI":"10.1152\/ajprenal.2000.278.5.F792","volume":"278","author":"M Traebert","year":"2000","unstructured":"Traebert M, V\u00f6lkl H, Biber J et al (2000) Luminal and contraluminal action of 1\u201334 and 3\u201334 PTH peptides on renal type IIa Na-Pi cotransporter. Am J Physiol Ren Physiol 278(5):F792\u2013F798. https:\/\/doi.org\/10.1152\/ajprenal.2000.278.5.F792","journal-title":"Am J Physiol Ren Physiol"},{"issue":"1","key":"11_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00424-002-0969-8","volume":"446","author":"D Bacic","year":"2003","unstructured":"Bacic D, Schulz N, Biber J et al (2003) Involvement of the MAPK-kinase pathway in the PTH-mediated regulation of the proximal tubule type IIa Na+\/Pi cotransporter in mouse kidney. Pflugers Arch 446(1):52\u201360. https:\/\/doi.org\/10.1007\/s00424-002-0969-8","journal-title":"Pflugers Arch"},{"issue":"4","key":"11_CR13","doi-asserted-by":"publisher","first-page":"F784","DOI":"10.1152\/ajprenal.1995.268.4.F784","volume":"268","author":"SA Kempson","year":"1995","unstructured":"Kempson SA, Lotscher M, Kaissling B et al (1995) Parathyroid hormone action on phosphate transporter mRNA and protein in rat renal proximal tubules. Am J Phys 268(4):F784\u2013F791. https:\/\/doi.org\/10.1152\/ajprenal.1995.268.4.F784","journal-title":"Am J Phys"},{"issue":"4","key":"11_CR14","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1046\/j.1523-1755.1998.00115.x","volume":"54","author":"I Keusch","year":"1998","unstructured":"Keusch I, Traebert M, L\u00f6tscher M et al (1998) Parathyroid hormone and dietary phosphate provoke a lysosomal routing of the proximal tubular Na\/Pi-cotransporter type II. Kidney Int 54(4):1224\u20131232. https:\/\/doi.org\/10.1046\/j.1523-1755.1998.00115.x","journal-title":"Kidney Int"},{"issue":"3","key":"11_CR15","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1210\/endo.134.3.8119156","volume":"134","author":"M Kaufmann","year":"1994","unstructured":"Kaufmann M, Muff R, Stieger B et al (1994) Apical and basolateral parathyroid hormone receptors in rat renal cortical membranes. Endocrinology 134(3):1173\u20131178. https:\/\/doi.org\/10.1210\/endo.134.3.8119156","journal-title":"Endocrinology"},{"issue":"4","key":"11_CR16","doi-asserted-by":"publisher","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","volume":"299","author":"V Lavi-Moshayoff","year":"2010","unstructured":"Lavi-Moshayoff V, Wasserman G, Meir T et al (2010) PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am J Physiol Ren Physiol 299(4):F882\u2013F889. https:\/\/doi.org\/10.1152\/ajprenal.00360.2010","journal-title":"Am J Physiol Ren Physiol"},{"issue":"9","key":"11_CR17","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1210\/jc.2007-1215","volume":"93","author":"MR Rubin","year":"2008","unstructured":"Rubin MR, Bilezikian JP, McMahon DJ et al (2008) The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab 93(9):3462\u20133470. https:\/\/doi.org\/10.1210\/jc.2007-1215","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"11_CR18","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1210\/endo.138.11.5505","volume":"138","author":"H Dobnig","year":"1997","unstructured":"Dobnig H, Turner RT (1997) The effects of programmed administration of human parathyroid hormone fragment (1\u201334) on bone histomorphometry and serum chemistry in rats. Endocrinology 138(11):4607\u20134612. https:\/\/doi.org\/10.1210\/endo.138.11.5505","journal-title":"Endocrinology"},{"issue":"5","key":"11_CR19","doi-asserted-by":"publisher","first-page":"326","DOI":"10.7326\/0003-4819-146-5-200703060-00005","volume":"146","author":"SL Greenspan","year":"2007","unstructured":"Greenspan SL, Bone HG, Ettinger MP et al (2007) Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis. Ann Intern Med 146(5):326\u2013339. https:\/\/doi.org\/10.7326\/0003-4819-146-5-200703060-00005","journal-title":"Ann Intern Med"},{"issue":"5","key":"11_CR20","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.clinthera.2014.04.001","volume":"36","author":"BL Clarke","year":"2014","unstructured":"Clarke BL, Kay Berg J, Fox J et al (2014) Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1\u201384) in patients with hypoparathyroidism: an open-label, single-dose, phase I study. Clin Ther 36(5):722\u2013736. https:\/\/doi.org\/10.1016\/j.clinthera.2014.04.001","journal-title":"Clin Ther"},{"issue":"12","key":"11_CR21","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1359\/jbmr.080803","volume":"23","author":"MR Rubin","year":"2008","unstructured":"Rubin MR, Dempster DW, Zhou H et al (2008) Dynamic and structural properties of the skeleton in hypoparathyroidism. J Bone Miner Res 23(12):2018\u20132024. https:\/\/doi.org\/10.1359\/jbmr.080803","journal-title":"J Bone Miner Res"},{"issue":"4","key":"11_CR22","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1152\/physrev.00022.2017","volume":"98","author":"T Michigami","year":"2018","unstructured":"Michigami T, Kawai M, Yamazaki M et al (2018) Phosphate as a signaling molecule and its sensing mechanism. Physiol Rev 98(4):2317\u20132348. https:\/\/doi.org\/10.1152\/physrev.00022.2017","journal-title":"Physiol Rev"},{"issue":"6","key":"11_CR23","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1074\/jbc.M117.807339","volume":"293","author":"N Bon","year":"2018","unstructured":"Bon N, Couasnay G, Bourgine A et al (2018) Phosphate (Pi)-regulated heterodimerization of the high-affinity sodium-dependent Pi transporters PiT1\/Slc20a1 and PiT2\/Slc20a2 underlies extracellular Pi sensing independently of Pi uptake. J Biol Chem 293(6):2102\u20132114. https:\/\/doi.org\/10.1074\/jbc.M117.807339","journal-title":"J Biol Chem"},{"key":"11_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.molmet.2018.02.007","volume":"11","author":"N Bon","year":"2018","unstructured":"Bon N, Frangi G, Sourice S et al (2018) Phosphate-dependent FGF23 secretion is modulated by PiT2\/Slc20a2. Mol Metab 11:197\u2013204. https:\/\/doi.org\/10.1016\/j.molmet.2018.02.007","journal-title":"Mol Metab"},{"issue":"2","key":"11_CR25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1080\/07435800.2016.1242604","volume":"42","author":"Y Takashi","year":"2017","unstructured":"Takashi Y, Kinoshita Y, Hori M et al (2017) Patients with FGF23-related hypophosphatemic rickets\/osteomalacia do not present with left ventricular hypertrophy. Endocr Res 42(2):132\u2013137. https:\/\/doi.org\/10.1080\/07435800.2016.1242604","journal-title":"Endocr Res"},{"issue":"27","key":"11_CR26","doi-asserted-by":"publisher","first-page":"18370","DOI":"10.1074\/jbc.M602469200","volume":"281","author":"K Kato","year":"2006","unstructured":"Kato K, Jeanneau C, Tarp MA et al (2006) Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis: secretion of fibroblast growth factor 23 requires O-glycosylation. J Biol Chem 281(27):18370\u201318377. https:\/\/doi.org\/10.1074\/jbc.M602469200","journal-title":"J Biol Chem"},{"issue":"11","key":"11_CR27","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1210\/jc.2009-0961","volume":"94","author":"C Bergwitz","year":"2009","unstructured":"Bergwitz C, Banerjee S, Abu-Zahra H et al (2009) Defective O-glycosylation due to a novel homozygous S129P mutation is associated with lack of fibroblast growth factor 23 secretion and tumoral calcinosis. J Clin Endocrinol Metab 94(11):4267\u20134274. https:\/\/doi.org\/10.1210\/jc.2009-0961","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"11_CR28","doi-asserted-by":"publisher","first-page":"11418","DOI":"10.1073\/pnas.1815166116","volume":"116","author":"Y Takashi","year":"2019","unstructured":"Takashi Y, Kosako H, Sawatsubashi S et al (2019) Activation of unliganded FGF receptor by extracellular phosphate potentiates proteolytic protection of FGF23 by its O-glycosylation. Proc Natl Acad Sci U S A 116(23):11418\u201311427. https:\/\/doi.org\/10.1073\/pnas.1815166116","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6455","key":"11_CR29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/366575a0","volume":"366","author":"EM Brown","year":"1993","unstructured":"Brown EM, Gamba G, Riccardi D et al (1993) Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid. Nature 366(6455):575\u2013580. https:\/\/doi.org\/10.1038\/366575a0","journal-title":"Nature"},{"issue":"1","key":"11_CR30","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1038\/s41467-019-12399-9","volume":"10","author":"PP Centeno","year":"2019","unstructured":"Centeno PP, Herberger A, Mun H et al (2019) Phosphate acts directly on the calcium-sensing receptor to stimulate parathyroid hormone secretion. Nat Commun 10(1):4693. https:\/\/doi.org\/10.1038\/s41467-019-12399-9","journal-title":"Nat Commun"},{"issue":"1","key":"11_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00223-020-00664-9","volume":"108","author":"E Koumakis","year":"2021","unstructured":"Koumakis E, Cormier C, Roux C et al (2021) The causes of hypo-and hyperphosphatemia in humans. Calcif Tissue Int 108(1):41\u201373. https:\/\/doi.org\/10.1007\/s00223-020-00664-9","journal-title":"Calcif Tissue Int"},{"issue":"10","key":"11_CR32","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1681\/ASN.V12102131","volume":"12","author":"SK Ganesh","year":"2001","unstructured":"Ganesh SK, Stack AG, Levin NW et al (2001) Association of elevated serum PO4, Ca\u00d7 PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12(10):2131\u20132138. https:\/\/doi.org\/10.1681\/ASN.V12102131","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"11_CR33","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1161\/hy1001.096358","volume":"38","author":"J Blacher","year":"2001","unstructured":"Blacher J, Guerin AP, Pannier B et al (2001) Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38(4):938\u2013942. https:\/\/doi.org\/10.1161\/hy1001.096358","journal-title":"Hypertension"},{"issue":"9","key":"11_CR34","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","volume":"18","author":"GM London","year":"2003","unstructured":"London GM, Guerin AP, Marchais SJ et al (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18(9):1731\u20131740","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"11_CR35","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","volume":"16","author":"B Kestenbaum","year":"2005","unstructured":"Kestenbaum B, Sampson JN, Rudser KD et al (2005) Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16(2):520\u2013528","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"11_CR36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ki.2011.69","volume":"80","author":"D Russo","year":"2011","unstructured":"Russo D, Corrao S, Battaglia Y et al (2011) Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis. Kidney Int 80(1):112\u2013118","journal-title":"Kidney Int"},{"issue":"2","key":"11_CR37","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3945\/ajcn.113.073148","volume":"99","author":"AR Chang","year":"2014","unstructured":"Chang AR, Lazo M, Appel LJ et al (2014) High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III. Am J Clin Nutr 99(2):320\u2013327","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"11_CR38","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archinte.167.9.879","volume":"167","author":"R Dhingra","year":"2007","unstructured":"Dhingra R, Sullivan LM, Fox CS et al (2007) Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167(9):879\u2013885","journal-title":"Arch Intern Med"},{"issue":"9","key":"11_CR39","doi-asserted-by":"crossref","first-page":"e74996","DOI":"10.1371\/journal.pone.0074996","volume":"8","author":"AP McGovern","year":"2013","unstructured":"McGovern AP, de Lusignan S, van Vlymen J et al (2013) Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community-based cohort study. PLoS One 8(9):e74996","journal-title":"PLoS One"},{"issue":"2","key":"11_CR40","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1681\/ASN.2008020141","volume":"20","author":"RN Foley","year":"2009","unstructured":"Foley RN, Collins AJ, Herzog CA et al (2009) Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 20(2):397\u2013404","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"11_CR41","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2215\/CJN.04100808","volume":"4","author":"JH Ix","year":"2009","unstructured":"Ix JH, De Boer IH, Peralta CA et al (2009) Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA. Clin J Am Soc Nephrol 4(3):609\u2013615","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"11_CR42","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/ATVBAHA.114.303440","volume":"34","author":"SM Kwak","year":"2014","unstructured":"Kwak SM, Kim JS, Choi Y et al (2014) Dietary intake of calcium and phosphorus and serum concentration in relation to the risk of coronary artery calcification in asymptomatic adults. Arterioscler Thromb Vasc Biol 34(8):1763\u20131769","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"11_CR43","doi-asserted-by":"crossref","first-page":"e0151007","DOI":"10.1371\/journal.pone.0151007","volume":"11","author":"KS Park","year":"2016","unstructured":"Park KS, Park J, Choi SH et al (2016) Serum phosphorus concentration and coronary artery calcification in subjects without renal dysfunction. PLoS One 11(3):e0151007","journal-title":"PLoS One"},{"issue":"8","key":"11_CR44","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/eurjhf\/hfq106","volume":"12","author":"R Dhingra","year":"2010","unstructured":"Dhingra R, Gona P, Benjamin EJ et al (2010) Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community. Eur J Heart Fail 12(8):812\u2013818","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"11_CR45","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ki.2012.303","volume":"83","author":"KT Yamamoto","year":"2013","unstructured":"Yamamoto KT, Robinson-Cohen C, De Oliveira MC et al (2013) Dietary phosphorus is associated with greater left ventricular mass. Kidney Int 83(4):707\u2013714","journal-title":"Kidney Int"},{"issue":"1","key":"11_CR46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000203348","volume":"32","author":"RN Foley","year":"2009","unstructured":"Foley RN, Collins AJ, Herzog CA et al (2009) Serum phosphate and left ventricular hypertrophy in young adults: the coronary artery risk development in young adults study. Kidney Blood Press Res 32(1):37\u201344","journal-title":"Kidney Blood Press Res"},{"issue":"8","key":"11_CR47","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1681\/ASN.2017121254","volume":"29","author":"J Mohammad","year":"2018","unstructured":"Mohammad J, Scanni R, Bestmann L et al (2018) A controlled increase in dietary phosphate elevates BP in healthy human subjects. J Am Soc Nephrol 29(8):2089\u20132098","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"11_CR48","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/ki.2008.644","volume":"75","author":"CM Giachelli","year":"2009","unstructured":"Giachelli CM (2009) The emerging role of phosphate in vascular calcification. Kidney Int 75(9):890\u2013897","journal-title":"Kidney Int"},{"issue":"11","key":"11_CR49","first-page":"2077","volume":"76","author":"J Voelkl","year":"2019","unstructured":"Voelkl J, Lang F, Eckardt K et al (2019) Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia. Cell Mol Life Sci 76(11):2077\u20132091","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"11_CR50","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1161\/ATVBAHA.106.132266","volume":"27","author":"R Villa-Bellosta","year":"2007","unstructured":"Villa-Bellosta R, Bogaert YE, Levi M et al (2007) Characterization of phosphate transport in rat vascular smooth muscle cells: implications for vascular calcification. Arterioscler Thromb Vasc Biol 27(5):1030\u20131036","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"11_CR51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.yexcr.2015.02.002","volume":"333","author":"NW Chavkin","year":"2015","unstructured":"Chavkin NW, Chia JJ, Crouthamel MH et al (2015) Phosphate uptake-independent signaling functions of the type III sodium-dependent phosphate transporter, PiT-1, in vascular smooth muscle cells. Exp Cell Res 333(1):39\u201348","journal-title":"Exp Cell Res"},{"issue":"7","key":"11_CR52","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.RES.0000216409.20863.e7","volume":"98","author":"X Li","year":"2006","unstructured":"Li X, Yang H, Giachelli CM (2006) Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 98(7):905\u2013912","journal-title":"Circ Res"},{"issue":"4","key":"11_CR53","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.kint.2018.05.015","volume":"94","author":"S Yamada","year":"2018","unstructured":"Yamada S, Leaf EM, Chia JJ et al (2018) PiT-2, a type III sodium-dependent phosphate transporter, protects against vascular calcification in mice with chronic kidney disease fed a high-phosphate diet. Kidney Int 94(4):716\u2013727","journal-title":"Kidney Int"},{"issue":"6","key":"11_CR54","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1159\/000485874","volume":"42","author":"D Zhang","year":"2017","unstructured":"Zhang D, Bi X, Liu Y et al (2017) High phosphate-induced calcification of vascular smooth muscle cells is associated with the TLR4\/NF-\u03bab signaling pathway. Kidney Blood Press Res 42(6):1205\u20131215","journal-title":"Kidney Blood Press Res"},{"issue":"7","key":"11_CR55","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1172\/JCI96477","volume":"128","author":"J Voelkl","year":"2018","unstructured":"Voelkl J, Luong TT, Tuffaha R et al (2018) SGK1 induces vascular smooth muscle cell calcification through NF-\u03baB signaling. J Clin Invest 128(7):3024\u20133040","journal-title":"J Clin Invest"},{"issue":"10","key":"11_CR56","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/ki.2011.18","volume":"79","author":"M Zhao","year":"2011","unstructured":"Zhao M, Xu M, Cai Y et al (2011) Mitochondrial reactive oxygen species promote p65 nuclear translocation mediating high-phosphate-induced vascular calcification in vitro and in vivo. Kidney Int 79(10):1071\u20131079","journal-title":"Kidney Int"},{"issue":"1","key":"11_CR57","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.bbrc.2009.12.027","volume":"391","author":"H Lee","year":"2010","unstructured":"Lee H, Woo KM, Ryoo H et al (2010) Tumor necrosis factor-\u03b1 increases alkaline phosphatase expression in vascular smooth muscle cells via MSX2 induction. Biochem Biophys Res Commun 391(1):1087\u20131092","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"11_CR58","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jbmr.2420","volume":"30","author":"CR Sheen","year":"2015","unstructured":"Sheen CR, Kuss P, Narisawa S et al (2015) Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification. J Bone Miner Res 30(5):824\u2013836","journal-title":"J Bone Miner Res"},{"issue":"11","key":"11_CR59","doi-asserted-by":"crossref","first-page":"e007248","DOI":"10.1161\/JAHA.117.007248","volume":"6","author":"T Yoshida","year":"2017","unstructured":"Yoshida T, Yamashita M, Horimai C et al (2017) Smooth muscle\u2013selective nuclear factor-\u03baB inhibition reduces phosphate-induced arterial medial calcification in mice with chronic kidney disease. J Am Heart Assoc 6(11):e007248","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"11_CR60","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1159\/000366400","volume":"34","author":"S Rong","year":"2014","unstructured":"Rong S, Zhao X, Jin X et al (2014) Vascular calcification in chronic kidney disease is induced by bone morphogenetic protein-2 via a mechanism involving the Wnt\/\u03b2-catenin pathway. Cell Physiol Biochem 34(6):2049\u20132060","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"11_CR61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000370250","volume":"41","author":"L Yao","year":"2015","unstructured":"Yao L, Sun Y, Sun W et al (2015) High phosphorus level leads to aortic calcification via \u03b2-catenin in chronic kidney disease. Am J Nephrol 41(1):28\u201336","journal-title":"Am J Nephrol"},{"issue":"1","key":"11_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-016-0362-8","volume":"16","author":"C Freise","year":"2016","unstructured":"Freise C, Kretzschmar N, Querfeld U (2016) Wnt signaling contributes to vascular calcification by induction of matrix metalloproteinases. BMC Cardiovasc Disord 16(1):1\u20138","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"11_CR63","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/nep.13677","volume":"25","author":"R Liao","year":"2020","unstructured":"Liao R, Wang L, Li J et al (2020) Vascular calcification is associated with Wnt-signaling pathway and blood pressure variability in chronic kidney disease rats. Nephrology 25(3):264\u2013272","journal-title":"Nephrology"},{"issue":"1","key":"11_CR64","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00223-016-0117-7","volume":"99","author":"D Deng","year":"2016","unstructured":"Deng D, Diao Z, Han X et al (2016) Secreted frizzled-related protein 5 attenuates high phosphate-induced calcification in vascular smooth muscle cells by inhibiting the wnt\/ss-catenin pathway. Calcif Tissue Int 99(1):66\u201375","journal-title":"Calcif Tissue Int"},{"issue":"8","key":"11_CR65","doi-asserted-by":"crossref","first-page":"F1136","DOI":"10.1152\/ajprenal.00684.2011","volume":"303","author":"JM Mart\u00ednez-Moreno","year":"2012","unstructured":"Mart\u00ednez-Moreno JM, Mu\u00f1oz-Casta\u00f1eda JR, Herencia C et al (2012) In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt\/\u03b2-catenin activation. Am J Physiol Ren Physiol 303(8):F1136\u2013F1144","journal-title":"Am J Physiol Ren Physiol"},{"issue":"4","key":"11_CR66","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1002\/jcp.26827","volume":"234","author":"B Tian","year":"2019","unstructured":"Tian B, Yao L, Sheng Z et al (2019) Specific knockdown of WNT8b expression protects against phosphate-induced calcification in vascular smooth muscle cells by inhibiting the Wnt\u2013\u03b2-catenin signaling pathway. J Cell Physiol 234(4):3469\u20133477","journal-title":"J Cell Physiol"},{"issue":"10","key":"11_CR67","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1111\/jcmm.14611","volume":"23","author":"P Zhou","year":"2019","unstructured":"Zhou P, Zhang X, Guo M et al (2019) Ginsenoside Rb1 ameliorates CKD-associated vascular calcification by inhibiting the Wnt\/\u03b2-catenin pathway. J Cell Mol Med 23(10):7088\u20137098","journal-title":"J Cell Mol Med"},{"issue":"3","key":"11_CR68","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2174\/1574888X10666150519093429","volume":"11","author":"Z Yuan","year":"2016","unstructured":"Yuan Z, Li Q, Luo S et al (2016) PPAR\u03b3 and Wnt signaling in adipogenic and osteogenic differentiation of mesenchymal stem cells. Curr Stem Cell Res Ther 11(3):216\u2013225","journal-title":"Curr Stem Cell Res Ther"},{"issue":"2","key":"11_CR69","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3892\/etm.2016.3996","volume":"13","author":"L Cheng","year":"2017","unstructured":"Cheng L, Zhang L, Yang J et al (2017) Activation of peroxisome proliferator-activated receptor \u03b3 inhibits vascular calcification by upregulating Klotho. Exp Ther Med 13(2):467\u2013474","journal-title":"Exp Ther Med"},{"key":"11_CR70","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.yjmcc.2017.11.021","volume":"114","author":"L Liu","year":"2018","unstructured":"Liu L, Liu Y, Zhang Y et al (2018) High phosphate-induced downregulation of PPAR\u03b3 contributes to CKD-associated vascular calcification. J Mol Cell Cardiol 114:264\u2013275","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"11_CR71","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.3892\/mmr.2017.7308","volume":"16","author":"M Gao","year":"2017","unstructured":"Gao M, Chen T, Wu L et al (2017) Effect of pioglitazone on the calcification of rat vascular smooth muscle cells through the downregulation of the Wnt\/\u03b2-catenin signaling pathway. Mol Med Rep 16(5):6208\u20136213","journal-title":"Mol Med Rep"},{"issue":"5","key":"11_CR72","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/10641963.2016.1163366","volume":"38","author":"L Cui","year":"2016","unstructured":"Cui L, Bai Y, Zhang J et al (2016) Effects of extracellular acid stimulation on rat vascular smooth muscle cell in Gas6\/Axl or PI3K\/Akt signaling pathway. Clin Exp Hypertens 38(5):451\u2013456","journal-title":"Clin Exp Hypertens"},{"issue":"4","key":"11_CR73","doi-asserted-by":"crossref","first-page":"e0196232","DOI":"10.1371\/journal.pone.0196232","volume":"13","author":"A Ponnusamy","year":"2018","unstructured":"Ponnusamy A, Sinha S, Hyde GD et al (2018) FTI-277 inhibits smooth muscle cell calcification by up-regulating PI3K\/Akt signaling and inhibiting apoptosis. PLoS One 13(4):e0196232","journal-title":"PLoS One"},{"issue":"24","key":"11_CR74","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1242\/jcs.023820","volume":"123","author":"C Frantz","year":"2010","unstructured":"Frantz C, Stewart KM, Weaver VM (2010) The extracellular matrix at a glance. J Cell Sci 123(24):4195\u20134200","journal-title":"J Cell Sci"},{"issue":"22","key":"11_CR75","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1161\/01.CIR.0000148367.08413.E9","volume":"110","author":"DM Basalyga","year":"2004","unstructured":"Basalyga DM, Simionescu DT, Xiong W et al (2004) Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation 110(22):3480\u20133487","journal-title":"Circulation"},{"issue":"2","key":"11_CR76","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ajpath.2010.10.006","volume":"178","author":"A Pai","year":"2011","unstructured":"Pai A, Leaf EM, El-Abbadi M et al (2011) Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease. Am J Pathol 178(2):764\u2013773","journal-title":"Am J Pathol"},{"issue":"6","key":"11_CR77","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.2215\/CJN.02120508","volume":"3","author":"K Amann","year":"2008","unstructured":"Amann K (2008) Media calcification and intima calcification are distinct entities in chronic kidney disease. Clin J Am Soc Nephrol 3(6):1599\u20131605","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"11_CR78","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/ki.2009.83","volume":"75","author":"MM El-Abbadi","year":"2009","unstructured":"El-Abbadi MM, Pai AS, Leaf EM et al (2009) Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin. Kidney Int 75(12):1297\u20131307","journal-title":"Kidney Int"},{"issue":"10","key":"11_CR79","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1681\/ASN.2010040349","volume":"21","author":"AS Pai","year":"2010","unstructured":"Pai AS, Giachelli CM (2010) Matrix remodeling in vascular calcification associated with chronic kidney disease. J Am Soc Nephrol 21(10):1637\u20131640","journal-title":"J Am Soc Nephrol"},{"issue":"13","key":"11_CR80","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1161\/CIRCULATIONAHA.108.827972","volume":"119","author":"E Aikawa","year":"2009","unstructured":"Aikawa E, Aikawa M, Libby P et al (2009) Clinical perspective. Circulation 119(13):1785\u20131794","journal-title":"Circulation"},{"issue":"3","key":"11_CR81","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000330175","volume":"34","author":"NX Chen","year":"2011","unstructured":"Chen NX, O\u2019Neill KD, Chen X et al (2011) Activation of arterial matrix metalloproteinases leads to vascular calcification in chronic kidney disease. Am J Nephrol 34(3):211\u2013219","journal-title":"Am J Nephrol"},{"issue":"5","key":"11_CR82","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/ndt\/gfv321","volume":"31","author":"E Hecht","year":"2016","unstructured":"Hecht E, Freise C, Websky K et al (2016) The matrix metalloproteinases 2 and 9 initiate uraemic vascular calcifications. Nephrol Dial Transplant 31(5):789\u2013797","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"11_CR83","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00223-009-9297-8","volume":"85","author":"N Hosaka","year":"2009","unstructured":"Hosaka N, Mizobuchi M, Ogata H et al (2009) Elastin degradation accelerates phosphate-induced mineralization of vascular smooth muscle cells. Calcif Tissue Int 85(6):523\u2013529","journal-title":"Calcif Tissue Int"},{"issue":"9","key":"11_CR84","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1161\/CIRCULATIONAHA.109.862565","volume":"120","author":"AW Chung","year":"2009","unstructured":"Chung AW, Yang HH, Kim JM et al (2009) Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease. Circulation 120(9):792\u2013801","journal-title":"Circulation"},{"issue":"4","key":"11_CR85","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/MAJ.0000000000000408","volume":"349","author":"Y Bai","year":"2015","unstructured":"Bai Y, Zhang J, Xu J et al (2015) Alteration of type I collagen in the radial artery of patients with end-stage renal disease. Am J Med Sci 349(4):292\u2013297","journal-title":"Am J Med Sci"},{"issue":"8","key":"11_CR86","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1096\/fj.201700653R","volume":"32","author":"E Jover","year":"2018","unstructured":"Jover E, Silvente A, Marin F et al (2018) Inhibition of enzymes involved in collagen cross-linking reduces vascular smooth muscle cell calcification. FASEB J 32(8):4459\u20134469","journal-title":"FASEB J"},{"issue":"1","key":"11_CR87","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00109-020-02014-6","volume":"99","author":"A Huang","year":"2021","unstructured":"Huang A, Guo G, Yu Y et al (2021) The roles of collagen in chronic kidney disease and vascular calcification. J Mol Med (Berl) 99(1):75\u201392","journal-title":"J Mol Med (Berl)"},{"key":"11_CR88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinorgbio.2018.05.007","volume":"186","author":"M Roszkowska","year":"2018","unstructured":"Roszkowska M, Strzelecka-Kiliszek A, Bessueille L et al (2018) Collagen promotes matrix vesicle-mediated mineralization by vascular smooth muscle cells. J Inorg Biochem 186:1\u20139","journal-title":"J Inorg Biochem"},{"issue":"12","key":"11_CR89","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1161\/01.ATV.18.12.1964","volume":"18","author":"KE Watson","year":"1998","unstructured":"Watson KE, Parhami F, Shin V et al (1998) Fibronectin and collagen I matrixes promote calcification of vascular cells in vitro, whereas collagen IV matrix is inhibitory. Arterioscler Thromb Vasc Biol 18(12):1964\u20131971","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"11_CR90","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.atherosclerosis.2013.02.041","volume":"229","author":"IG Nikolov","year":"2013","unstructured":"Nikolov IG, Joki N, Galmiche A et al (2013) Farnesyltransferase inhibitor R115777 protects against vascular disease in uremic mice. Atherosclerosis 229(1):42\u201351","journal-title":"Atherosclerosis"},{"issue":"17","key":"11_CR91","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.108.783738","volume":"118","author":"RC Shroff","year":"2008","unstructured":"Shroff RC, McNair R, Figg N et al (2008) Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 118(17):1748\u20131757","journal-title":"Circulation"},{"issue":"11","key":"11_CR92","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/01.RES.87.11.1055","volume":"87","author":"D Proudfoot","year":"2000","unstructured":"Proudfoot D, Skepper JN, Hegyi L et al (2000) Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 87(11):1055\u20131062","journal-title":"Circ Res"},{"issue":"12","key":"11_CR93","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1161\/CIRCRESAHA.108.175976","volume":"102","author":"MC Clarke","year":"2008","unstructured":"Clarke MC, Littlewood TD, Figg N et al (2008) Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration. Circ Res 102(12):1529\u20131538","journal-title":"Circ Res"},{"issue":"8","key":"11_CR94","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/01.RES.0000218859.90970.8d","volume":"98","author":"B Son","year":"2006","unstructured":"Son B, Kozaki K, Iijima K et al (2006) Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway. Circ Res 98(8):1024\u20131031","journal-title":"Circ Res"},{"issue":"9","key":"11_CR95","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/ATVBAHA.110.216739","volume":"31","author":"A Takemura","year":"2011","unstructured":"Takemura A, Iijima K, Ota H et al (2011) Sirtuin 1 retards hyperphosphatemia-induced calcification of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 31(9):2054\u20132062","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"11_CR96","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00223-014-9929-5","volume":"96","author":"S Yamada","year":"2015","unstructured":"Yamada S, Tatsumoto N, Tokumoto M et al (2015) Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model. Calcif Tissue Int 96(4):347\u2013358","journal-title":"Calcif Tissue Int"},{"key":"11_CR97","doi-asserted-by":"crossref","first-page":"111124","DOI":"10.1016\/j.mad.2019.111124","volume":"182","author":"D Xu","year":"2019","unstructured":"Xu D, Zeng F, Han L et al (2019) The synergistic action of phosphate and interleukin-6 enhances senescence-associated calcification in vascular smooth muscle cells depending on p53. Mech Ageing Dev 182:111124","journal-title":"Mech Ageing Dev"},{"issue":"6","key":"11_CR98","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/ki.2012.482","volume":"83","author":"X Dai","year":"2013","unstructured":"Dai X, Zhao M, Cai Y et al (2013) Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release. Kidney Int 83(6):1042\u20131051","journal-title":"Kidney Int"},{"issue":"1","key":"11_CR99","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000356656","volume":"33","author":"D Liu","year":"2014","unstructured":"Liu D, Cui W, Liu B et al (2014) Atorvastatin protects vascular smooth muscle cells from TGF-\u03b21-stimulated calcification by inducing autophagy via suppression of the \u03b2-catenin pathway. Cell Physiol Biochem 33(1):129\u2013141","journal-title":"Cell Physiol Biochem"},{"key":"11_CR100","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.3389\/fimmu.2018.01866","volume":"9","author":"B Frauscher","year":"2018","unstructured":"Frauscher B, Kirsch AH, Schabh\u00fcttl C et al (2018) Autophagy protects from uremic vascular media calcification. Front Immunol 9:1866","journal-title":"Front Immunol"},{"key":"11_CR101","doi-asserted-by":"crossref","first-page":"118121","DOI":"10.1016\/j.lfs.2020.118121","volume":"261","author":"T Xu","year":"2020","unstructured":"Xu T, Sheng Z, Li Y et al (2020) OGT knockdown counteracts high phosphate-induced vascular calcification in chronic kidney disease through autophagy activation by downregulating YAP. Life Sci 261:118121","journal-title":"Life Sci"},{"issue":"23","key":"11_CR102","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/eurheartj\/ehu163","volume":"35","author":"P Lanzer","year":"2014","unstructured":"Lanzer P, Boehm M, Sorribas V et al (2014) Medial vascular calcification revisited: review and perspectives. Eur Heart J 35(23):1515\u20131525","journal-title":"Eur Heart J"},{"key":"11_CR103","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.atherosclerosis.2020.03.007","volume":"306","author":"R Villa-Bellosta","year":"2020","unstructured":"Villa-Bellosta R (2020) New insights into endogenous mechanisms of protection against arterial calcification. Atherosclerosis 306:68\u201374","journal-title":"Atherosclerosis"},{"issue":"7","key":"11_CR104","doi-asserted-by":"crossref","first-page":"e0159858","DOI":"10.1371\/journal.pone.0159858","volume":"11","author":"R Villa-Bellosta","year":"2016","unstructured":"Villa-Bellosta R, Gonz\u00e1lez-Parra E, Egido J (2016) Alkalosis and dialytic clearance of phosphate increases phosphatase activity: a hidden consequence of hemodialysis. PLoS One 11(7):e0159858","journal-title":"PLoS One"},{"issue":"8","key":"11_CR105","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1681\/ASN.2004080694","volume":"16","author":"KA Lomashvili","year":"2005","unstructured":"Lomashvili KA, Khawandi W, O\u2019Neill WC (2005) Reduced plasma pyrophosphate levels in hemodialysis patients. J Am Soc Nephrol 16(8):2495\u20132500","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"11_CR106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-29432-4","volume":"8","author":"D Azpiazu","year":"2018","unstructured":"Azpiazu D, Gonz\u00e1lez-Parra E, Egido J et al (2018) Hydrolysis of extracellular pyrophosphate increases in post-hemodialysis plasma. Sci Rep 8(1):1\u20138","journal-title":"Sci Rep"},{"issue":"6","key":"11_CR107","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/ki.2013.521","volume":"85","author":"KA Lomashvili","year":"2014","unstructured":"Lomashvili KA, Narisawa S, Mill\u00e1n JL et al (2014) Vascular calcification is dependent on plasma levels of pyrophosphate. Kidney Int 85(6):1351\u20131356","journal-title":"Kidney Int"},{"issue":"11","key":"11_CR108","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1253\/circj.CJ-11-0477","volume":"75","author":"R Villa-Bellosta","year":"2011","unstructured":"Villa-Bellosta R, Sorribas V (2011) Calcium phosphate deposition with normal phosphate concentration\u2013role of pyrophosphate. Circ J 75(11):2705\u20132710","journal-title":"Circ J"},{"issue":"10","key":"11_CR109","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1093\/ndt\/gfr039","volume":"26","author":"BL Riser","year":"2011","unstructured":"Riser BL, Barreto FC, Rezg R et al (2011) Daily peritoneal administration of sodium pyrophosphate in a dialysis solution prevents the development of vascular calcification in a mouse model of uraemia. Nephrol Dial Transplant 26(10):3349\u20133357","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"11_CR110","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/ki.2010.461","volume":"79","author":"WC O\u2019neill","year":"2011","unstructured":"O\u2019neill WC, Lomashvili KA, Malluche HH et al (2011) Treatment with pyrophosphate inhibits uremic vascular calcification. Kidney Int 79(5):512\u2013517","journal-title":"Kidney Int"},{"issue":"1","key":"11_CR111","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3906\/sag-1809-43","volume":"49","author":"R Mutluay","year":"2019","unstructured":"Mutluay R, De\u011fertekin CK, DER\u0130C\u0130 \u00dc et al (2019) Serum fetuin-A is associated with the components of MIAC (malnutrition, inflammation, atherosclerosis, calcification) syndrome in different stages. Turk J Med Sci 49(1):327\u2013335","journal-title":"Turk J Med Sci"},{"issue":"8","key":"11_CR112","doi-asserted-by":"crossref","first-page":"F744","DOI":"10.1152\/ajprenal.00017.2015","volume":"309","author":"S Yamada","year":"2015","unstructured":"Yamada S, Tokumoto M, Tsuruya K et al (2015) Fetuin-A decrease induced by a low-protein diet enhances vascular calcification in uremic rats with hyperphosphatemia. Am J Physiol Ren Physiol 309(8):F744\u2013F754","journal-title":"Am J Physiol Ren Physiol"},{"issue":"6","key":"11_CR113","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1681\/ASN.2008060572","volume":"20","author":"R Westenfeld","year":"2009","unstructured":"Westenfeld R, Sch\u00e4fer C, Kr\u00fcger T et al (2009) Fetuin-A protects against atherosclerotic calcification in CKD. J Am Soc Nephrol 20(6):1264\u20131274","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"11_CR114","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/ndt\/gfm094","volume":"22","author":"R Westenfeld","year":"2007","unstructured":"Westenfeld R, Sch\u00e4fer C, Smeets R et al (2007) Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrol Dial Transplant 22(6):1537\u20131546","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"11_CR115","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1111\/j.1523-1755.2005.00333.x","volume":"67","author":"SM Moe","year":"2005","unstructured":"Moe SM, Reslerova M, Ketteler M et al (2005) Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 67(6):2295\u20132304","journal-title":"Kidney Int"},{"issue":"5","key":"11_CR116","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000095782","volume":"26","author":"M Cozzolino","year":"2006","unstructured":"Cozzolino M, Galassi A, Biondi ML et al (2006) Serum fetuin-A levels link inflammation and cardiovascular calcification in hemodialysis patients. Am J Nephrol 26(5):423\u2013429","journal-title":"Am J Nephrol"},{"issue":"5","key":"11_CR117","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3889\/oamjms.2019.167","volume":"7","author":"RA Muzasti","year":"2019","unstructured":"Muzasti RA, Loesnihari R (2019) High fetuin-A level as a protective factor to abdominal aortic calcification in Indonesian regular hemodialysis patients. Open Access Maced J Med Sci 7(5):721","journal-title":"Open Access Maced J Med Sci"},{"issue":"1","key":"11_CR118","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11255-017-1740-6","volume":"50","author":"O Ulutas","year":"2018","unstructured":"Ulutas O, Taskapan MC, Dogan A et al (2018) Vascular calcification is not related to serum fetuin-A and osteopontin levels in hemodialysis patients. Int Urol Nephrol 50(1):137\u2013142","journal-title":"Int Urol Nephrol"},{"issue":"6620","key":"11_CR119","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/386078a0","volume":"386","author":"G Luo","year":"1997","unstructured":"Luo G, Ducy P, McKee MD et al (1997) Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386(6620):78\u201381","journal-title":"Nature"},{"issue":"11","key":"11_CR120","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1359\/jbmr.090508","volume":"24","author":"M Julien","year":"2009","unstructured":"Julien M, Khoshniat S, Lacreusette A et al (2009) Phosphate-dependent regulation of MGP in osteoblasts: role of ERK1\/2 and Fra-1. J Bone Miner Res 24(11):1856\u20131868","journal-title":"J Bone Miner Res"},{"issue":"2","key":"11_CR121","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1210\/en.2006-0763","volume":"148","author":"M Julien","year":"2007","unstructured":"Julien M, Magne D, Masson M et al (2007) Phosphate stimulates matrix Gla protein expression in chondrocytes through the extracellular signal regulated kinase signaling pathway. Endocrinology 148(2):530\u2013537","journal-title":"Endocrinology"},{"issue":"4","key":"11_CR122","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/ndt\/gfs520","volume":"28","author":"L Louvet","year":"2013","unstructured":"Louvet L, B\u00fcchel J, Steppan S et al (2013) Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant 28(4):869\u2013878. https:\/\/doi.org\/10.1093\/ndt\/gfs520","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"11_CR123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-017-0609-3","volume":"18","author":"M Aoun","year":"2017","unstructured":"Aoun M, Makki M, Azar H et al (2017) High dephosphorylated-uncarboxylated MGP in hemodialysis patients: risk factors and response to vitamin K 2, a pre-post intervention clinical trial. BMC Nephrol 18(1):1\u201310","journal-title":"BMC Nephrol"},{"issue":"1","key":"11_CR124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2369-15-1","volume":"15","author":"P Delanaye","year":"2014","unstructured":"Delanaye P, Krzesinski J, Warling X et al (2014) Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients. BMC Nephrol 15(1):1\u20138","journal-title":"BMC Nephrol"},{"issue":"3","key":"11_CR125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000453368","volume":"135","author":"S Thamratnopkoon","year":"2017","unstructured":"Thamratnopkoon S, Susantitaphong P, Tumkosit M et al (2017) Correlations of plasma desphosphorylated uncarboxylated matrix Gla protein with vascular calcification and vascular stiffness in chronic kidney disease. Nephron 135(3):167\u2013172","journal-title":"Nephron"},{"issue":"2","key":"11_CR126","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1523-1755.2002.00170.x","volume":"61","author":"SM Moe","year":"2002","unstructured":"Moe SM, O\u2019Neill KD, Duan D et al (2002) Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 61(2):638\u2013647","journal-title":"Kidney Int"},{"issue":"15","key":"11_CR127","doi-asserted-by":"crossref","first-page":"8352","DOI":"10.1073\/pnas.140021997","volume":"97","author":"GR Beck","year":"2000","unstructured":"Beck GR, Zerler B, Moran E (2000) Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci U S A 97(15):8352\u20138357","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"11_CR128","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1046\/j.1523-1755.2002.00625.x","volume":"62","author":"NX Chen","year":"2002","unstructured":"Chen NX, O\u2019Neill KD, Duan D et al (2002) Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int 62(5):1724\u20131731","journal-title":"Kidney Int"},{"issue":"7","key":"11_CR129","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.RES.0000161997.24797.c0","volume":"96","author":"CM Giachelli","year":"2005","unstructured":"Giachelli CM, Speer MY, Li X et al (2005) Regulation of vascular calcification: roles of phosphate and osteopontin. Circ Res 96(7):717\u2013722","journal-title":"Circ Res"},{"issue":"2","key":"11_CR130","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/01.RES.84.2.166","volume":"84","author":"T Wada","year":"1999","unstructured":"Wada T, McKee MD, Steitz S et al (1999) Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ Res 84(2):166\u2013178","journal-title":"Circ Res"},{"issue":"2","key":"11_CR131","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cardiores.2005.01.023","volume":"66","author":"MY Speer","year":"2005","unstructured":"Speer MY, Chien Y, Quan M et al (2005) Smooth muscle cells deficient in osteopontin have enhanced susceptibility to calcification in vitro. Cardiovasc Res 66(2):324\u2013333","journal-title":"Cardiovasc Res"},{"issue":"5","key":"11_CR132","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.kint.2015.12.046","volume":"89","author":"NJ Paloian","year":"2016","unstructured":"Paloian NJ, Leaf EM, Giachelli CM (2016) Osteopontin protects against high phosphate-induced nephrocalcinosis and vascular calcification. Kidney Int 89(5):1027\u20131036","journal-title":"Kidney Int"},{"issue":"2","key":"11_CR133","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2008.09.033","volume":"204","author":"A Van Campenhout","year":"2009","unstructured":"Van Campenhout A, Golledge J (2009) Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis 204(2):321\u2013329","journal-title":"Atherosclerosis"},{"issue":"8","key":"11_CR134","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.3390\/ijms21082685","volume":"21","author":"SJ Lee","year":"2020","unstructured":"Lee SJ, Lee I, Jeon J (2020) Vascular calcification\u2014New insights into Its mechanism. Int J Mol Sci 21(8):2685","journal-title":"Int J Mol Sci"},{"issue":"9","key":"11_CR135","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1161\/ATVBAHA.107.147868","volume":"27","author":"Y Orita","year":"2007","unstructured":"Orita Y, Yamamoto H, Kohno N et al (2007) Role of osteoprotegerin in arterial calcification: development of new animal model. Arterioscler Thromb Vasc Biol 27(9):2058\u20132064","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"11_CR136","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0272-6386(03)00655-3","volume":"42","author":"K Nitta","year":"2003","unstructured":"Nitta K, Akiba T, Uchida K et al (2003) The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. Am J Kidney Dis 42(2):303\u2013309","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"11_CR137","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1093\/ndt\/gfp253","volume":"24","author":"MK Sigrist","year":"2009","unstructured":"Sigrist MK, Levin A, Er L et al (2009) Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification. Nephrol Dial Transplant 24(10):3157\u20133162","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"11_CR138","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/ndt\/gfp301","volume":"24","author":"M Morena","year":"2009","unstructured":"Morena M, Dupuy A, Jaussent I et al (2009) A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients. Nephrol Dial Transplant 24(11):3389\u20133397","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"11_CR139","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1515\/CCLM.2009.075","volume":"47","author":"M Mesquita","year":"2009","unstructured":"Mesquita M, Demulder A, Damry N et al (2009) Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease. Clin Chem Lab Med 47(3):339\u2013346","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"11_CR140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jash.2017.09.013","volume":"12","author":"M Desjardins","year":"2018","unstructured":"Desjardins M, Sidib\u00e9 A, Fortier C et al (2018) Association of interleukin-6 with aortic stiffness in end-stage renal disease. J Am Soc Hypertens 12(1):5\u201313","journal-title":"J Am Soc Hypertens"},{"issue":"9","key":"11_CR141","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/ndt\/gfp191","volume":"24","author":"G Jean","year":"2009","unstructured":"Jean G, Terrat J, Vanel T et al (2009) High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. Nephrol Dial Transplant 24(9):2792\u20132796","journal-title":"Nephrol Dial Transplant"},{"key":"11_CR142","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.carpath.2017.01.004","volume":"27","author":"K Benz","year":"2017","unstructured":"Benz K, Varga I, Neureiter D et al (2017) Vascular inflammation and media calcification are already present in early stages of chronic kidney disease. Cardiovasc Pathol 27:57\u201367","journal-title":"Cardiovasc Pathol"},{"issue":"21","key":"11_CR143","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1161\/01.CIR.102.21.2636","volume":"102","author":"Y Tintut","year":"2000","unstructured":"Tintut Y, Patel J, Parhami F et al (2000) Tumor necrosis factor-\u03b1 promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102(21):2636\u20132642","journal-title":"Circulation"},{"issue":"3","key":"11_CR144","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.ijcard.2013.01.211","volume":"168","author":"C Wen","year":"2013","unstructured":"Wen C, Yang X, Yan Z et al (2013) Nalp3 inflammasome is activated and required for vascular smooth muscle cell calcification. Int J Cardiol 168(3):2242\u20132247","journal-title":"Int J Cardiol"},{"issue":"3","key":"11_CR145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/0394632016689571","volume":"30","author":"M Sun","year":"2017","unstructured":"Sun M, Chang Q, Xin M et al (2017) Endogenous bone morphogenetic protein 2 plays a role in vascular smooth muscle cell calcification induced by interleukin 6 in vitro. Int J Immunopathol Pharmacol 30(3):227\u2013237","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"12","key":"11_CR146","doi-asserted-by":"crossref","first-page":"F1418","DOI":"10.1152\/ajprenal.00633.2013","volume":"306","author":"S Yamada","year":"2014","unstructured":"Yamada S, Tokumoto M, Tatsumoto N et al (2014) Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia. Am J Physiol Ren Physiol 306(12):F1418\u2013F1428","journal-title":"Am J Physiol Ren Physiol"},{"issue":"6","key":"11_CR147","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/ajh\/hpu225","volume":"28","author":"M Agharazii","year":"2015","unstructured":"Agharazii M, St-Louis R, Gautier-Bastien A et al (2015) Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification. Am J Hypertens 28(6):746\u2013755","journal-title":"Am J Hypertens"},{"key":"11_CR148","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.atherosclerosis.2016.05.044","volume":"251","author":"P Aghagolzadeh","year":"2016","unstructured":"Aghagolzadeh P, Bachtler M, Bijarnia R et al (2016) Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-\u03b1. Atherosclerosis 251:404\u2013414","journal-title":"Atherosclerosis"},{"issue":"13","key":"11_CR149","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1042\/CS20160807","volume":"131","author":"JM Mart\u00ednez-Moreno","year":"2017","unstructured":"Mart\u00ednez-Moreno JM, Herencia C, de Oca AM et al (2017) High phosphate induces a pro-inflammatory response by vascular smooth muscle cells and modulation by vitamin D derivatives. Clin Sci 131(13):1449\u20131463","journal-title":"Clin Sci"},{"issue":"3","key":"11_CR150","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1159\/000313831","volume":"115","author":"N Wang","year":"2010","unstructured":"Wang N, Wang X, Xing C et al (2010) Role of TGF-\u03b21 in bone matrix production in vascular smooth muscle cells induced by a high-phosphate environment. Nephron Exp Nephrol 115(3):e60\u2013e68","journal-title":"Nephron Exp Nephrol"},{"issue":"10","key":"11_CR151","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/ATVBAHA.117.309161","volume":"37","author":"K Zhang","year":"2017","unstructured":"Zhang K, Zhang Y, Feng W et al (2017) Interleukin-18 enhances vascular calcification and osteogenic differentiation of vascular smooth muscle cells through TRPM7 activation. Arterioscler Thromb Vasc Biol 37(10):1933\u20131943","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"11_CR152","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.trsl.2007.12.005","volume":"151","author":"Z Al-Aly","year":"2008","unstructured":"Al-Aly Z (2008) Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opathy. Transl Res 151(5):233\u2013239","journal-title":"Transl Res"},{"issue":"5","key":"11_CR153","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1172\/JCI24140","volume":"115","author":"J Shao","year":"2005","unstructured":"Shao J, Cheng S, Pingsterhaus JM et al (2005) Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 115(5):1210\u20131220","journal-title":"J Clin Invest"},{"issue":"4","key":"11_CR154","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ndt\/gfx316","volume":"33","author":"D Zickler","year":"2018","unstructured":"Zickler D, Luecht C, Willy K et al (2018) Tumour necrosis factor-alpha in uraemic serum promotes osteoblastic transition and calcification of vascular smooth muscle cells via extracellular signal-regulated kinases and activator protein 1\/c-FOS-mediated induction of interleukin 6 expression. Nephrol Dial Transplant 33(4):574\u2013585","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"11_CR155","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1159\/000341216","volume":"49","author":"KA Deuell","year":"2012","unstructured":"Deuell KA, Callegari A, Giachelli CM et al (2012) RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-\u03b1. J Vasc Res 49(6):510\u2013521","journal-title":"J Vasc Res"},{"issue":"2","key":"11_CR156","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000358920","volume":"51","author":"A Callegari","year":"2014","unstructured":"Callegari A, Coons ML, Ricks JL et al (2014) Increased calcification in osteoprotegerin-deficient smooth muscle cells: dependence on receptor activator of NF-\u03baB ligand and interleukin 6. J Vasc Res 51(2):118\u2013131","journal-title":"J Vasc Res"},{"issue":"10","key":"11_CR157","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1681\/ASN.2014030230","volume":"26","author":"CB Leibrock","year":"2015","unstructured":"Leibrock CB, Alesutan I, Voelkl J et al (2015) NH4Cl treatment prevents tissue calcification in klotho deficiency. J Am Soc Nephrol 26(10):2423\u20132433","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"11_CR158","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1172\/JCI117205","volume":"93","author":"KE Watson","year":"1994","unstructured":"Watson KE, Bostr\u00f6m K, Ravindranath R et al (1994) TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 93(5):2106\u20132113","journal-title":"J Clin Invest"},{"issue":"1","key":"11_CR159","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5301\/jn.5000127","volume":"26","author":"N Wang","year":"2013","unstructured":"Wang N, Wang X, Sun B et al (2013) Role of TGF-\u03b21 in production of fibronectin in vascular smooth muscle cells cultured under high-phosphate conditions. J Nephrol 26(1):213\u2013218","journal-title":"J Nephrol"},{"issue":"4","key":"11_CR160","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MNH.0000000000000609","volume":"29","author":"ER Smith","year":"2020","unstructured":"Smith ER, Hewitson TD, Jahnen-Dechent W (2020) Calciprotein particles: mineral behaving badly? Curr Opin Nephrol Hypertens 29(4):378\u2013386","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"5","key":"11_CR161","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3390\/jcm9051287","volume":"9","author":"CN Silaghi","year":"2020","unstructured":"Silaghi CN, Ily\u00e9s T, Van Ballegooijen AJ et al (2020) Calciprotein particles and serum calcification propensity: hallmarks of vascular calcifications in patients with chronic kidney disease. J Clin Med 9(5):1287","journal-title":"J Clin Med"},{"issue":"1","key":"11_CR162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"ER Smith","year":"2017","unstructured":"Smith ER, Hewitson TD, Cai MM et al (2017) A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum. Sci Rep 7(1):1\u201317","journal-title":"Sci Rep"},{"issue":"3","key":"11_CR163","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/nep.12994","volume":"23","author":"H Yamada","year":"2018","unstructured":"Yamada H, Kuro-o M, Ishikawa S et al (2018) Daily variability in serum levels of calciprotein particles and their association with mineral metabolism parameters: a cross-sectional pilot study. Nephrology 23(3):226\u2013230","journal-title":"Nephrology"},{"key":"11_CR164","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.3389\/fimmu.2018.01991","volume":"9","author":"S K\u00f6ppert","year":"2018","unstructured":"K\u00f6ppert S, B\u00fcscher A, Babler A et al (2018) Cellular clearance and biological activity of calciprotein particles depend on their maturation state and crystallinity. Front Immunol 9:1991","journal-title":"Front Immunol"},{"issue":"5","key":"11_CR165","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCRESAHA.111.261479","volume":"111","author":"M Herrmann","year":"2012","unstructured":"Herrmann M, Sch\u00e4fer C, Heiss A et al (2012) Clearance of fetuin-A\u2013containing calciprotein particles is mediated by scavenger receptor-A. Circ Res 111(5):575\u2013584","journal-title":"Circ Res"},{"issue":"2","key":"11_CR166","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1681\/ASN.2013060635","volume":"25","author":"ER Smith","year":"2014","unstructured":"Smith ER, Ford ML, Tomlinson LA et al (2014) Serum calcification propensity predicts all-cause mortality in predialysis CKD. J Am Soc Nephrol 25(2):339\u2013348","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"11_CR167","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jjcc.2019.04.008","volume":"74","author":"J Nakazato","year":"2019","unstructured":"Nakazato J, Hoshide S, Wake M et al (2019) Association of calciprotein particles measured by a new method with coronary artery plaque in patients with coronary artery disease: a cross-sectional study. J Cardiol 74(5):428\u2013435","journal-title":"J Cardiol"},{"issue":"10","key":"11_CR168","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1681\/ASN.2012030240","volume":"23","author":"A Pasch","year":"2012","unstructured":"Pasch A, Farese S, Gr\u00e4ber S et al (2012) Nanoparticle-based test measures overall propensity for calcification in serum. J Am Soc Nephrol 23(10):1744\u20131752","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"11_CR169","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2215\/CJN.04720416","volume":"12","author":"A Pasch","year":"2017","unstructured":"Pasch A, Block GA, Bachtler M et al (2017) Blood calcification propensity, cardiovascular events, and survival in patients receiving hemodialysis in the EVOLVE trial. Clin J Am Soc Nephrol 12(2):315\u2013322","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"11_CR170","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1053\/j.ajkd.2019.01.024","volume":"73","author":"JD Bundy","year":"2019","unstructured":"Bundy JD, Cai X, Scialla JJ et al (2019) Serum calcification propensity and coronary artery calcification among patients with CKD: the CRIC (Chronic Renal Insufficiency Cohort) study. Am J Kidney Dis 73(6):806\u2013814","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"11_CR171","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2215\/CJN.04710419","volume":"14","author":"JD Bundy","year":"2019","unstructured":"Bundy JD, Cai X, Mehta RC et al (2019) Serum calcification propensity and clinical events in CKD. Clin J Am Soc Nephrol 14(11):1562\u20131571","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"11_CR172","doi-asserted-by":"crossref","first-page":"e60904","DOI":"10.1371\/journal.pone.0060904","volume":"8","author":"ER Smith","year":"2013","unstructured":"Smith ER, Hanssen E, McMahon LP et al (2013) Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage. PLoS One 8(4):e60904","journal-title":"PLoS One"},{"issue":"3","key":"11_CR173","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/heartjnl-2011-300570","volume":"98","author":"CD Chue","year":"2012","unstructured":"Chue CD, Edwards NC, Moody WE et al (2012) Serum phosphate is associated with left ventricular mass in patients with chronic kidney disease: a cardiac magnetic resonance study. Heart 98(3):219\u2013224","journal-title":"Heart"},{"key":"11_CR174","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijcard.2016.06.181","volume":"221","author":"J Zou","year":"2016","unstructured":"Zou J, Yu Y, Wu P et al (2016) Serum phosphorus is related to left ventricular remodeling independent of renal function in hospitalized patients with chronic kidney disease. Int J Cardiol 221:134\u2013140","journal-title":"Int J Cardiol"},{"key":"11_CR175","doi-asserted-by":"crossref","unstructured":"Faul C, Amaral AP, Oskouei B et al (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121(11)","DOI":"10.1172\/JCI46122"},{"issue":"2","key":"11_CR176","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/MAJ.0b013e3181815498","volume":"337","author":"HJ Hsu","year":"2009","unstructured":"Hsu HJ, Wu M (2009) Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients. Am J Med Sci 337(2):116\u2013122","journal-title":"Am J Med Sci"},{"issue":"2","key":"11_CR177","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","volume":"207","author":"MA Mirza","year":"2009","unstructured":"Mirza MA, Larsson A, Melhus H et al (2009) Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis 207(2):546\u2013551","journal-title":"Atherosclerosis"},{"issue":"4","key":"11_CR178","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/ndt\/gfq539","volume":"26","author":"A Kirkpantur","year":"2011","unstructured":"Kirkpantur A, Balci M, Gurbuz OA et al (2011) Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients. Nephrol Dial Transplant 26(4):1346\u20131354","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"11_CR179","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00467-012-2347-x","volume":"28","author":"R Shroff","year":"2013","unstructured":"Shroff R (2013) Phosphate is a vascular toxin. Pediatr Nephrol 28(4):583\u2013593","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"11_CR180","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","volume":"22","author":"A Grabner","year":"2015","unstructured":"Grabner A, Amaral AP, Schramm K et al (2015) Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy. Cell Metab 22(6):1020\u20131032","journal-title":"Cell Metab"},{"issue":"6","key":"11_CR181","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1681\/ASN.2014050465","volume":"26","author":"MC Hu","year":"2015","unstructured":"Hu MC, Shi M, Cho HJ et al (2015) Klotho and phosphate are modulators of pathologic uremic cardiac remodeling. J Am Soc Nephrol 26(6):1290\u20131302","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"11_CR182","first-page":"411","volume":"35","author":"MC Hu","year":"2020","unstructured":"Hu MC, Scanni R, Ye J et al (2020) Dietary vitamin D interacts with high phosphate-induced cardiac remodeling in rats with normal renal function. Nephrol Dial Transplant 35(3):411\u2013421","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"11_CR183","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1161\/CIRCULATIONAHA.118.037550","volume":"139","author":"P Peri-Okonny","year":"2019","unstructured":"Peri-Okonny P, Baskin KK, Iwamoto G et al (2019) High-phosphate diet induces exercise intolerance and impairs fatty acid metabolism in mice. Circulation 139(11):1422\u20131434","journal-title":"Circulation"},{"key":"11_CR184","doi-asserted-by":"publisher","unstructured":"Moench I, Aravindhan K, Kuziw J et al (2021) High FGF23 levels failed to predict cardiac hypertrophy in animal models of hyperphosphatemia and chronic renal failure. J Endocr Soc. https:\/\/doi.org\/10.1210\/jendso\/bvab066","DOI":"10.1210\/jendso\/bvab066"},{"issue":"4","key":"11_CR185","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1046\/j.1523-1755.2003.00864.x","volume":"63","author":"K Amann","year":"2003","unstructured":"Amann K, T\u00f6rnig J, Kugel B et al (2003) Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. Kidney Int 63(4):1296\u20131301","journal-title":"Kidney Int"},{"issue":"6","key":"11_CR186","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/j.1523-1755.2004.66013.x","volume":"66","author":"KR Neves","year":"2004","unstructured":"Neves KR, Graciolli FG, Dos Reis LM et al (2004) Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure. Kidney Int 66(6):2237\u20132244","journal-title":"Kidney Int"},{"issue":"1","key":"11_CR187","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13993-7","volume":"11","author":"Y Huang","year":"2020","unstructured":"Huang Y, Wang S, Zhou J et al (2020) IRF1-mediated downregulation of PGC1\u03b1 contributes to cardiorenal syndrome type 4. Nat Commun 11(1):1\u201316","journal-title":"Nat Commun"},{"issue":"1","key":"11_CR188","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3945\/an.113.004861","volume":"5","author":"MS Calvo","year":"2014","unstructured":"Calvo MS, Moshfegh AJ, Tucker KL (2014) Assessing the health impact of phosphorus in the food supply: issues and considerations. Adv Nutr 5(1):104\u2013113","journal-title":"Adv Nutr"},{"issue":"4","key":"11_CR189","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MNH.0000000000000503","volume":"28","author":"H Kim","year":"2019","unstructured":"Kim H, Mizuno M, Vongpatanasin W (2019) Phosphate, the forgotten mineral in hypertension. Curr Opin Nephrol Hypertens 28(4):345","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"10","key":"11_CR190","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1097\/HJH.0000000000000659","volume":"33","author":"RK Patel","year":"2015","unstructured":"Patel RK, Jeemon P, Stevens KK et al (2015) Association between serum phosphate and calcium, long-term blood pressure, and mortality in treated hypertensive adults. J Hypertens 33(10):2046\u20132053","journal-title":"J Hypertens"},{"issue":"6","key":"11_CR191","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pbj.2017.02.005","volume":"2","author":"M Mendes","year":"2017","unstructured":"Mendes M, Resende L, Teixeira A et al (2017) Blood pressure and phosphate level in diabetic and non-diabetic kidney disease: results of the cross-sectional \u201cLow Clearance Consultation\u201d study. Porto Biomed J 2(6):301\u2013305","journal-title":"Porto Biomed J"},{"issue":"1","key":"11_CR192","first-page":"R39","volume":"311","author":"M Mizuno","year":"2016","unstructured":"Mizuno M, Mitchell JH, Crawford S et al (2016) High dietary phosphate intake induces hypertension and augments exercise pressor reflex function in rats. Am J Phys Regul Integr Comp Phys 311(1):R39\u2013R48","journal-title":"Am J Phys Regul Integr Comp Phys"},{"issue":"1","key":"11_CR193","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/cvr\/cvs240","volume":"96","author":"I Six","year":"2012","unstructured":"Six I, Maizel J, Barreto FC et al (2012) Effects of phosphate on vascular function under normal conditions and influence of the uraemic state. Cardiovasc Res 96(1):130\u2013139. https:\/\/doi.org\/10.1093\/cvr\/cvs240","journal-title":"Cardiovasc Res"},{"issue":"9","key":"11_CR194","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1097\/HJH.0000000000000261","volume":"32","author":"M Bozic","year":"2014","unstructured":"Bozic M, Panizo S, Sevilla MA et al (2014) High phosphate diet increases arterial blood pressure via a parathyroid hormone mediated increase of renin. J Hypertens 32(9):1822\u20131832","journal-title":"J Hypertens"},{"issue":"10","key":"11_CR195","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.amjmed.2005.02.014","volume":"118","author":"A Gaasbeek","year":"2005","unstructured":"Gaasbeek A, Meinders AE (2005) Hypophosphatemia: an update on its etiology and treatment. Am J Med 118(10):1094\u20131101. https:\/\/doi.org\/10.1016\/j.amjmed.2005.02.014","journal-title":"Am J Med"},{"issue":"11","key":"11_CR196","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/archinte.167.11.1159","volume":"167","author":"D Martins","year":"2007","unstructured":"Martins D, Wolf M, Pan D et al (2007) Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data From the Third National Health and Nutrition Examination Survey. Arch Intern Med 167(11):1159\u20131165. https:\/\/doi.org\/10.1001\/archinte.167.11.1159","journal-title":"Arch Intern Med"},{"issue":"1","key":"11_CR197","doi-asserted-by":"publisher","first-page":"E125","DOI":"10.1152\/ajpendo.00224.2004","volume":"288","author":"W Xiang","year":"2005","unstructured":"Xiang W, Kong J, Chen S et al (2005) Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 288(1):E125\u2013E132. https:\/\/doi.org\/10.1152\/ajpendo.00224.2004","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"11_CR198","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jsbmb.2006.12.098","volume":"103","author":"RU Simpson","year":"2007","unstructured":"Simpson RU, Hershey SH, Nibbelink KA (2007) Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol 103(3):521\u2013524","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"11_CR199","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pcad.2018.02.001","volume":"61","author":"EL O\u2019Keefe","year":"2018","unstructured":"O\u2019Keefe EL, DiNicolantonio JJ, O\u2019Keefe JH et al (2018) Alcohol and CV health: jekyll and hyde J-curves. Prog Cardiovasc Dis 61(1):68\u201375","journal-title":"Prog Cardiovasc Dis"},{"key":"11_CR200","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fphys.2016.00173","volume":"7","author":"MJ Wacker","year":"2016","unstructured":"Wacker MJ, Touchberry CD, Silswal N et al (2016) Skeletal muscle, but not cardiovascular function, is altered in a mouse model of autosomal recessive hypophosphatemic rickets. Front Physiol 7:173. https:\/\/doi.org\/10.3389\/fphys.2016.00173","journal-title":"Front Physiol"},{"issue":"2","key":"11_CR201","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1388-9842(01)00234-3","volume":"4","author":"HJ Milionis","year":"2002","unstructured":"Milionis HJ, Alexandrides GE, Liberopoulos EN et al (2002) Hypomagnesemia and concurrent acid\u2013base and electrolyte abnormalities in patients with congestive heart failure. Eur J Heart Fail 4(2):167\u2013173","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"11_CR202","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ijcard.2014.09.034","volume":"177","author":"P Rozentryt","year":"2014","unstructured":"Rozentryt P, Nowak J, Niedziela J et al (2014) Serum phosphorus level is related to degree of clinical response to up-titration of heart failure pharmacotherapy. Int J Cardiol 177(1):248\u2013254. https:\/\/doi.org\/10.1016\/j.ijcard.2014.09.034","journal-title":"Int J Cardiol"},{"issue":"1","key":"11_CR203","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5049\/EBP.2014.12.1.19","volume":"12","author":"A Schwartz","year":"2014","unstructured":"Schwartz A, Brotfain E, Koyfman L et al (2014) Association between hypophosphatemia and cardiac arrhythmias in the early stage of sepsis: could phosphorus replacement treatment reduce the incidence of arrhythmias? Electrolyte Blood Press 12(1):19\u201325. https:\/\/doi.org\/10.5049\/EBP.2014.12.1.19","journal-title":"Electrolyte Blood Press"},{"issue":"829","key":"11_CR204","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1136\/pgmj.70.829.825","volume":"70","author":"AK Cariem","year":"1994","unstructured":"Cariem AK, Lemmer ER, Adams MG et al (1994) Severe hypophosphataemia in anorexia nervosa. Postgrad Med J 70(829):825\u2013827. https:\/\/doi.org\/10.1136\/pgmj.70.829.825","journal-title":"Postgrad Med J"},{"issue":"4","key":"11_CR205","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1097\/IJG.0000000000000185","volume":"24","author":"C Hu","year":"2015","unstructured":"Hu C, Lee B, Cheng H et al (2015) Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient. J Glaucoma 24(4):e31\u2013e33. https:\/\/doi.org\/10.1097\/IJG.0000000000000185","journal-title":"J Glaucoma"},{"issue":"16","key":"11_CR206","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2169\/internalmedicine.48.2236","volume":"48","author":"A Osuka","year":"2009","unstructured":"Osuka A, Matsuoka T, Idoguchi K (2009) Is this the worst outcome of metabolic syndrome? Hypophosphatemia and resulting cardiac arrest during the treatment of diabetic ketoacidosis with hypertriglyceridemia. Intern Med 48(16):1391\u20131395. https:\/\/doi.org\/10.2169\/internalmedicine.48.2236","journal-title":"Intern Med"},{"issue":"17","key":"11_CR207","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1056\/NEJM197710272971702","volume":"297","author":"LR O\u2019Connor","year":"1977","unstructured":"O\u2019Connor LR, Wheeler WS, Bethune JE (1977) Effect of hypophosphatemia on myocardial performance in man. N Engl J Med 297(17):901\u2013903. https:\/\/doi.org\/10.1056\/NEJM197710272971702","journal-title":"N Engl J Med"},{"issue":"10","key":"11_CR208","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1007\/BF01700966","volume":"21","author":"J Zazzo","year":"1995","unstructured":"Zazzo J, Troch\u00e9 G, Ruel P et al (1995) High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function. Intensive Care Med 21(10):826\u2013831. https:\/\/doi.org\/10.1007\/BF01700966","journal-title":"Intensive Care Med"},{"issue":"1","key":"11_CR209","first-page":"13","volume":"151","author":"A Rasmussen","year":"1985","unstructured":"Rasmussen A, Buus S, Hessov I (1985) Postoperative myocardial performance during glucose-induced hypophosphatemia. Acta Chir Scand 151(1):13\u201315","journal-title":"Acta Chir Scand"},{"issue":"3","key":"11_CR210","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00000441-198803000-00004","volume":"295","author":"SV Davis","year":"1988","unstructured":"Davis SV, Olichwier KK, Chakko SC (1988) Reversible depression of myocardial performance in hypophosphatemia. Am J Med Sci 295(3):183\u2013187","journal-title":"Am J Med Sci"},{"issue":"2","key":"11_CR211","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/ng1095-130","volume":"11","author":"F Francis","year":"1995","unstructured":"Francis F, Hennig S, Korn B et al (1995) A gene (PEX) with homologies to endopeptidases is mutated in patients with X\u2013linked hypophosphatemic rickets. Nat Genet 11(2):130\u2013136. https:\/\/doi.org\/10.1038\/ng1095-130","journal-title":"Nat Genet"},{"issue":"11","key":"11_CR212","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1210\/jc.2002-021105","volume":"87","author":"Y Yamazaki","year":"2002","unstructured":"Yamazaki Y, Okazaki R, Shibata M et al (2002) Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. J Clin Endocrinol Metab 87(11):4957\u20134960. https:\/\/doi.org\/10.1210\/jc.2002-021105","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"11_CR213","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00467-002-1044-6","volume":"18","author":"US Alon","year":"2003","unstructured":"Alon US, Monzavi R, Lilien M et al (2003) Hypertension in hypophosphatemic rickets\u2014role of secondary hyperparathyroidism. Pediatr Nephrol 18(2):155\u2013158. https:\/\/doi.org\/10.1007\/s00467-002-1044-6","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"11_CR214","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1210\/jcem.82.8.4181","volume":"82","author":"R Nehgme","year":"1997","unstructured":"Nehgme R, Fahey JT, Smith C et al (1997) Cardiovascular abnormalities in patients with X-linked hypophosphatemia. J Clin Endocrinol Metab 82(8):2450\u20132454. https:\/\/doi.org\/10.1210\/jcem.82.8.4181","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"11_CR215","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00467-018-4180-3","volume":"34","author":"O Hern\u00e1ndez-Fr\u00edas","year":"2019","unstructured":"Hern\u00e1ndez-Fr\u00edas O, Gil-Pe\u00f1a H, P\u00e9rez-Rold\u00e1n JM et al (2019) Risk of cardiovascular involvement in pediatric patients with X-linked hypophosphatemia. Pediatr Nephrol 34(6):1077\u20131086. https:\/\/doi.org\/10.1007\/s00467-018-4180-3","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"11_CR216","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1507\/endocrj.EJ16-0199","volume":"64","author":"Y Nakamura","year":"2017","unstructured":"Nakamura Y, Takagi M, Takeda R et al (2017) Hypertension is a characteristic complication of X-linked hypophosphatemia. Endocr J 64(3):283\u2013289. https:\/\/doi.org\/10.1507\/endocrj.EJ16-0199","journal-title":"Endocr J"},{"issue":"4","key":"11_CR217","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/0002-8703(84)90337-5","volume":"107","author":"Z Vered","year":"1984","unstructured":"Vered Z, Battler A, Motro M et al (1984) Left ventricular function in patients with chronic hypophosphatemia. Am Heart J 107(4):796\u2013798","journal-title":"Am Heart J"},{"issue":"5","key":"11_CR218","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jbmr.5650050508","volume":"5","author":"I Vered","year":"1990","unstructured":"Vered I, Whyte MP, Vered Z et al (1990) Normal left ventricular performance in children with x-linked hypophosphatemic rickets: a doppler echocardiography study. J Bone Miner Res 5(5):469\u2013474","journal-title":"J Bone Miner Res"},{"key":"11_CR219","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fendo.2018.00333","volume":"9","author":"M Leifheit-Nestler","year":"2018","unstructured":"Leifheit-Nestler M, Richter B, Basaran M et al (2018) Impact of altered mineral metabolism on pathological cardiac remodeling in elevated fibroblast growth factor 23. Front Endocrinol 9:333. https:\/\/doi.org\/10.3389\/fendo.2018.00333","journal-title":"Front Endocrinol"},{"issue":"5","key":"11_CR220","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1210\/en.2018-00174","volume":"159","author":"ES Liu","year":"2018","unstructured":"Liu ES, Thoonen R, Petit E et al (2018) Increased circulating FGF23 does not lead to cardiac hypertrophy in the male hyp mouse model of XLH. Endocrinology 159(5):2165\u20132172. https:\/\/doi.org\/10.1210\/en.2018-00174","journal-title":"Endocrinology"},{"issue":"6","key":"11_CR221","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/emmm.201303716","volume":"6","author":"O Andrukhova","year":"2014","unstructured":"Andrukhova O, Slavic S, Smorodchenko A et al (2014) FGF23 regulates renal sodium handling and blood pressure. EMBO Mol Med 6(6):744\u2013759","journal-title":"EMBO Mol Med"},{"issue":"1","key":"11_CR222","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1681\/ASN.2017040412","volume":"29","author":"X Han","year":"2018","unstructured":"Han X, Ross J, Kolumam G et al (2018) Cardiovascular effects of renal distal tubule deletion of the FGF receptor 1 gene. J Am Soc Nephrol 29(1):69\u201380. https:\/\/doi.org\/10.1681\/ASN.2017040412","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"11_CR223","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.kint.2018.02.017","volume":"94","author":"E Pastor-Arroyo","year":"2018","unstructured":"Pastor-Arroyo E, Gehring N, Krudewig C et al (2018) The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk. Kidney Int 94(1):49\u201359. https:\/\/doi.org\/10.1016\/j.kint.2018.02.017","journal-title":"Kidney Int"},{"issue":"11","key":"11_CR224","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/ng1868","volume":"38","author":"B Lorenz-Depiereux","year":"2006","unstructured":"Lorenz-Depiereux B, Bastepe M, Benet-Pag\u00e8s A et al (2006) DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet 38(11):1248\u20131250. https:\/\/doi.org\/10.1038\/ng1868","journal-title":"Nat Genet"},{"issue":"11","key":"11_CR225","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/ng1905","volume":"38","author":"JQ Feng","year":"2006","unstructured":"Feng JQ, Ward LM, Liu S et al (2006) Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 38(11):1310\u20131315. https:\/\/doi.org\/10.1038\/ng1905","journal-title":"Nat Genet"},{"issue":"2","key":"11_CR226","doi-asserted-by":"publisher","first-page":"E254","DOI":"10.1152\/ajpendo.90201.2008","volume":"295","author":"S Liu","year":"2008","unstructured":"Liu S, Zhou J, Tang W et al (2008) Pathogenic role of Fgf23 in Dmp1-null mice. Am J Physiol Endocrinol Metab 295(2):E254\u2013E261. https:\/\/doi.org\/10.1152\/ajpendo.90201.2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"11_CR227","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1172\/JCI109239","volume":"62","author":"TJ Fuller","year":"1978","unstructured":"Fuller TJ, Nichols WW, Brenner BJ et al (1978) Reversible depression in myocardial performance in dogs with experimental phosphorus deficiency. J Clin Invest 62(6):1194\u20131200. https:\/\/doi.org\/10.1172\/JCI109239","journal-title":"J Clin Invest"},{"issue":"2","key":"11_CR228","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/cvr\/16.2.71","volume":"16","author":"JM Capasso","year":"1982","unstructured":"Capasso JM, Aronson RS, Strobeck JE et al (1982) Effects of experimental phosphate deficiency on action potential characteristics and contractile performance of rat myocardium. Cardiovasc Res 16(2):71\u201379. https:\/\/doi.org\/10.1093\/cvr\/16.2.71","journal-title":"Cardiovasc Res"},{"issue":"7","key":"11_CR229","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0953-6205(02)00130-9","volume":"13","author":"A Schwartz","year":"2002","unstructured":"Schwartz A, Gurman GM, Cohen G et al (2002) Association between hypophosphatemia and cardiac arrhythmias in the early stages of sepsis. Eur J Intern Med 13(7):434\u2013438","journal-title":"Eur J Intern Med"},{"issue":"2","key":"11_CR230","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ejcts.2004.03.004","volume":"26","author":"J Cohen","year":"2004","unstructured":"Cohen J, Kogan A, Sahar G et al (2004) Hypophosphatemia following open heart surgery: incidence and consequences. Eur J Cardiothorac Surg 26(2):306\u2013310. https:\/\/doi.org\/10.1016\/j.ejcts.2004.03.004","journal-title":"Eur J Cardiothorac Surg"},{"issue":"12","key":"11_CR231","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.1365-2044.2006.04839.x","volume":"61","author":"RM Heames","year":"2006","unstructured":"Heames RM, Cope RA (2006) Hypophosphataemia causing profound cardiac failure after cardiac surgery. Anaesthesia 61(12):1211\u20131213","journal-title":"Anaesthesia"},{"issue":"708","key":"11_CR232","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1136\/pgmj.60.708.679","volume":"60","author":"A Frustaci","year":"1984","unstructured":"Frustaci A, Pennestr\u00ec, Scoppetta C (1984) Myocardial damage due to hypokalaemia and hypophosphataemia. Postgrad Med J 60(708):679\u2013681. https:\/\/doi.org\/10.1136\/pgmj.60.708.679","journal-title":"Postgrad Med J"},{"issue":"3","key":"11_CR233","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ahj.2008.05.016","volume":"156","author":"RN Foley","year":"2008","unstructured":"Foley RN, Collins AJ, Ishani A et al (2008) Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 156(3):556\u2013563","journal-title":"Am Heart J"},{"issue":"2","key":"11_CR234","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/ATVBAHA.109.196675","volume":"30","author":"TE Larsson","year":"2010","unstructured":"Larsson TE, Olauson H, Hagstr\u00f6m E et al (2010) Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community. Arterioscler Thromb Vasc Biol 30(2):333\u2013339. https:\/\/doi.org\/10.1161\/ATVBAHA.109.196675","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"11_CR235","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler M, Block GA, Evenepoel P et al (2017) Executive summary of the 2017 KDIGO Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD-MBD) guideline update: what\u2019s changed and why it matters. Kidney Int 92(1):26\u201336","journal-title":"Kidney Int"},{"issue":"6","key":"11_CR236","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ki.2013.213","volume":"84","author":"JL Finch","year":"2013","unstructured":"Finch JL, Lee DH, Liapis H et al (2013) Phosphate restriction significantly reduces mortality in uremic rats with established vascular calcification. Kidney Int 84(6):1145\u20131153","journal-title":"Kidney Int"},{"issue":"4","key":"11_CR237","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2215\/CJN.07640711","volume":"7","author":"B Di Iorio","year":"2012","unstructured":"Di Iorio B, Di Micco L, Torraca S et al (2012) Acute effects of very-low-protein diet on FGF23 levels: a randomized study. Clin J Am Soc Nephrol 7(4):581\u2013587. https:\/\/doi.org\/10.2215\/CJN.07640711","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"11_CR238","doi-asserted-by":"publisher","first-page":"286","DOI":"10.2215\/CJN.05420709","volume":"5","author":"RB Oliveira","year":"2010","unstructured":"Oliveira RB, Cancela ALE, Graciolli FG et al (2010) Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy? Clin J Am Soc Nephrol 5(2):286\u2013291. https:\/\/doi.org\/10.2215\/CJN.05420709","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"11_CR239","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1681\/ASN.2012030223","volume":"23","author":"GA Block","year":"2012","unstructured":"Block GA, Wheeler DC, Persky MS et al (2012) Effects of phosphate binders in moderate CKD. J Am Soc Nephrol 23(8):1407\u20131415. https:\/\/doi.org\/10.1681\/ASN.2012030223","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"11_CR240","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.ki.5002518","volume":"72","author":"D Russo","year":"2007","unstructured":"Russo D, Miranda I, Ruocco C et al (2007) The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int 72(10):1255\u20131261","journal-title":"Kidney Int"},{"issue":"3","key":"11_CR241","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2215\/CJN.05170513","volume":"9","author":"K Yokoyama","year":"2014","unstructured":"Yokoyama K, Hirakata H, Akiba T et al (2014) Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD. Clin J Am Soc Nephrol 9(3):543\u2013552. https:\/\/doi.org\/10.2215\/CJN.05170513","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"11_CR242","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1681\/ASN.2018101016","volume":"30","author":"GA Block","year":"2019","unstructured":"Block GA, Block MS, Smits G et al (2019) A pilot randomized trial of ferric citrate coordination complex for the treatment of advanced CKD. J Am Soc Nephrol 30(8):1495\u20131504. https:\/\/doi.org\/10.1681\/ASN.2018101016","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"11_CR243","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.2215\/CJN.09250912","volume":"8","author":"T Isakova","year":"2013","unstructured":"Isakova T, Barchi-Chung A, Enfield G et al (2013) Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD. Clin J Am Soc Nephrol 8(6):1009\u20131018. https:\/\/doi.org\/10.2215\/CJN.09250912","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"11_CR244","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ki.2013.110","volume":"84","author":"J Maizel","year":"2013","unstructured":"Maizel J, Six I, Dupont S et al (2013) Effects of sevelamer treatment on cardiovascular abnormalities in mice with chronic renal failure. Kidney Int 84(3):491\u2013500","journal-title":"Kidney Int"},{"issue":"7","key":"11_CR245","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/ndt\/gfy318","volume":"34","author":"GA Block","year":"2019","unstructured":"Block GA, Pergola PE, Fishbane S et al (2019) Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses. Nephrol Dial Transplant 34(7):1115\u20131124. https:\/\/doi.org\/10.1093\/ndt\/gfy318","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"11_CR246","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2015.290","volume":"89","author":"V David","year":"2016","unstructured":"David V, Martin A, Isakova T et al (2016) Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney Int 89(1):135\u2013146","journal-title":"Kidney Int"},{"issue":"6","key":"11_CR247","doi-asserted-by":"publisher","first-page":"F1369","DOI":"10.1152\/ajprenal.00281.2016","volume":"311","author":"MR Hanudel","year":"2016","unstructured":"Hanudel MR, Chua K, Rappaport M et al (2016) Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice. Am J Physiol Ren Physiol 311(6):F1369\u2013F1377. https:\/\/doi.org\/10.1152\/ajprenal.00281.2016","journal-title":"Am J Physiol Ren Physiol"},{"issue":"6","key":"11_CR248","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.kint.2019.07.026","volume":"96","author":"C Francis","year":"2019","unstructured":"Francis C, Courbon G, Gerber C et al (2019) Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease. Kidney Int 96(6):1346\u20131358","journal-title":"Kidney Int"},{"key":"11_CR249","doi-asserted-by":"publisher","unstructured":"Spencer AG, Labonte ED, Rosenbaum DP et al (2014) Intestinal inhibition of the Na+\/H+ exchanger 3 prevents cardiorenal damage in rats and inhibits Na+ uptake in humans. Sci Transl Med 6(227). https:\/\/doi.org\/10.1126\/scitranslmed.3007790","DOI":"10.1126\/scitranslmed.3007790"},{"issue":"5","key":"11_CR250","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1681\/ASN.2014030317","volume":"26","author":"ED Labont\u00e9","year":"2015","unstructured":"Labont\u00e9 ED, Carreras CW, Leadbetter MR et al (2015) Gastrointestinal inhibition of sodium-hydrogen exchanger 3 reduces phosphorus absorption and protects against vascular calcification in CKD. J Am Soc Nephrol 26(5):1138\u20131149. https:\/\/doi.org\/10.1681\/ASN.2014030317","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"11_CR251","doi-asserted-by":"publisher","first-page":"5372","DOI":"10.1073\/pnas.95.9.5372","volume":"95","author":"L Beck","year":"1998","unstructured":"Beck L, Karaplis AC, Amizuka N et al (1998) Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci U S A 95(9):5372\u20135377. https:\/\/doi.org\/10.1073\/pnas.95.9.5372","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR252","doi-asserted-by":"publisher","unstructured":"Klar J, Anja G, Ehrmann A et al (2020) MO053(ABSTRACT) inhibition of sodium phoshate transporter NPT2A improves experimental vascular calcificatio and phosphate homeostasis in rats. Nephrol Dial Transplant 35. https:\/\/doi.org\/10.1093\/ndt\/gfaa140.MO053","DOI":"10.1093\/ndt\/gfaa140.MO053"},{"issue":"2","key":"11_CR253","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1086\/499409","volume":"78","author":"C Bergwitz","year":"2006","unstructured":"Bergwitz C, Roslin NM, Tieder M et al (2006) SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am J Hum Genet 78(2):179\u2013192","journal-title":"Am J Hum Genet"},{"issue":"6","key":"11_CR254","doi-asserted-by":"publisher","first-page":"F1271","DOI":"10.1152\/ajprenal.00252.2003","volume":"285","author":"HS Tenenhouse","year":"2003","unstructured":"Tenenhouse HS, Martel J, Gauthier C et al (2003) Differential effects of Npt2a gene ablation and X-linked Hyp mutation on renal expression of Npt2c. Am J Phys Renal Phys 285(6):F1271\u2013F1278. https:\/\/doi.org\/10.1152\/ajprenal.00252.2003","journal-title":"Am J Phys Renal Phys"},{"key":"11_CR255","doi-asserted-by":"publisher","unstructured":"Montes de Oca A, Guerrero F, Martinez-Moreno J et al (2014) Magnesium inhibits Wnt\/\u03b2-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells. PLoS One 9(2). https:\/\/doi.org\/10.1371\/journal.pone.0089525","DOI":"10.1371\/journal.pone.0089525"},{"issue":"1","key":"11_CR256","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1038\/s41598-018-20241-3","volume":"8","author":"AD ter Braake","year":"2018","unstructured":"ter Braake AD, Tinnemans PT, Shanahan CM et al (2018) Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation. Sci Rep 8(1):2069. https:\/\/doi.org\/10.1038\/s41598-018-20241-3","journal-title":"Sci Rep"},{"key":"11_CR257","doi-asserted-by":"publisher","unstructured":"Sakaguchi Y, Fujii N, Shoji T et al (2015) Magnesium modifies the cardiovascular mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis: a cohort study. PLoS One 9(12). https:\/\/doi.org\/10.1371\/journal.pone.0116273","DOI":"10.1371\/journal.pone.0116273"},{"issue":"6","key":"11_CR258","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/FJC.0000000000000590","volume":"72","author":"Z Yao","year":"2018","unstructured":"Yao Z, Xu Y, Ma W et al (2018) Magnesium citrate protects against vascular calcification in an adenine-induced chronic renal failure rat model. J Cardiovasc Pharmacol 72(6):270\u2013276. https:\/\/doi.org\/10.1097\/FJC.0000000000000590","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"11_CR259","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.kint.2017.04.011","volume":"92","author":"J Diaz-Tocados","year":"2017","unstructured":"Diaz-Tocados J, Peralta-Ramirez A, Rodr\u00edguez-Ortiz ME et al (2017) Dietary magnesium supplementation prevents and reverses vascular and soft tissue calcifications in uremic rats. Kidney Int 92(5):1084\u20131099","journal-title":"Kidney Int"},{"issue":"1","key":"11_CR260","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/ndt\/gfy410","volume":"35","author":"N Kaesler","year":"2020","unstructured":"Kaesler N, Goettsch C, Weis D et al (2020) Magnesium but not nicotinamide prevents vascular calcification in experimental uraemia. Nephrol Dial Transplant 35(1):65\u201373. https:\/\/doi.org\/10.1093\/ndt\/gfy410","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"11_CR261","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1681\/ASN.2018111150","volume":"30","author":"Y Sakaguchi","year":"2019","unstructured":"Sakaguchi Y, Hamano T, Obi Y et al (2019) A randomized trial of magnesium oxide and oral carbon adsorbent for coronary artery calcification in predialysis CKD. J Am Soc Nephrol 30(6):1073\u20131085. https:\/\/doi.org\/10.1681\/ASN.2018111150","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"11_CR262","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.2215\/CJN.13921217","volume":"13","author":"I Bressendorff","year":"2018","unstructured":"Bressendorff I, Hansen D, Schou M et al (2018) The effect of increasing dialysate magnesium on serum calcification propensity in subjects with end stage kidney disease. Clin J Am Soc Nephrol 13(9):1373\u20131380. https:\/\/doi.org\/10.2215\/CJN.13921217","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Advances in Experimental Medicine and Biology","Phosphate Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-91623-7_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T19:12:45Z","timestamp":1647285165000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-91623-7_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783030916213","9783030916237"],"references-count":262,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-91623-7_11","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"15 March 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}